Rainier Arnolda
PhD Candidate at Monash Business School
Embedded Files
About Me
I am a first year PhD student in the Centre for Health Economics at Monash University and a medical scientist with a background of diagnostic cancer genetics.
Contact information:
Contact information:
Email: Rainier.Arnolda@monash.edu
Research Interests:
Research Interests:
Health Economic Evaluation
Health Technology Assessment
Health Economic Modelling
Supervisors:
Supervisors:
Professor Dennis Petrie
Dr Laura Fanning
Dr Adam Irving
Research
Research
My research aims to explore the cost effectiveness of immunoglobulin therapy and its role in preventing infection in patients with multiple myeloma.
Education:
Education:
Master of Public Health, University of Melbourne (2018-2021)
Master of Laboratory Medicine (Distinction), RMIT University
Honours and Awards:
Honours and Awards:
Monash Graduate Excellence Scholarship
Publications:
Publications:
Arnolda R, Howlett K, Chan T, Raleigh J, Hatzimihalis A, Bell A, Fellowes A, Sandhu S, McArthur GA, Fox SB, Dawson SJ, Hewitt C, Jones K, Wong SQ. Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA. Pathology. 2022 Oct;54(6):772-778. doi: 10.1016/j.pathol.2022.02.010. Epub 2022 May 23. PMID: 35618509.
Prall, O. W., Browning, J., Nastevski, V., Caporarello, S., Bates, B., Hewitt, C. A., Arenas, A., Lamb, G., Howlett, K., Arnolda, R. and Adeloju, R, et al. 2022, 'ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance,' PATHOLOGY, vol.54, no.3, pp. 279-285. doi:10.1016/j.pathol.2021.07.006.
CALDWELL, I., YAP, Y. Z., DOWLING, M. R., SAGHEBI, J., WONG, A. J. N., LEGAIE, R., ARNOLDA, R., WILSON, C., IGNACIO, D., O'LEARY, N., YAUNG, S., SU, B., WOESTMANN, C., DICKINSON, M., THOMPSON, E. & BLOMBERY, P. 2023. Clinical Utility of Circulating Tumor (ct)DNA Quantity and Kinetics in Patients Undergoing CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma. Blood, 142, 7160.
Research Experience:
Research Experience:
Research Support: Pharmaceutical Benefit Advisory Committee (PBAC) evaluation, Melbourne School of Population and Global Health (2022-2023)
Disclaimer: This is a personal webpage. The ideas and information expressed on it have not been approved or authorised by Monash University either explicitly or by implication. In no event shall Monash University be liable for any damages whatsoever resulting from any action arising in connection with the use of this information or its publication, including any action for infringement of copyright or defamation.
We acknowledge and pay respects to the Elders and Traditional Owners of the land.
Page updated
Report abuse